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Staphylococcus epidermidis is a bacterium frequently isolated from contaminated platelet
concentrates (PCs), a blood product used to treat bleeding disorders in transfusion patients.
PCs offer an accidental niche for colonization of S. epidermidis by forming biofilms and thus
avoiding clearance by immune factors present in this milieu. Using biochemical and micros-
copy techniques, we investigated the structural changes of the peptidoglycan (PG) and the
biofilm matrix of S. epidermidis biofilms formed in whole-blood derived PCs compared to
biofilms grown in glucose-supplemented trypticase soy broth (TSBg). Both, the PG and the
biofilm matrix are primary mechanisms of defense against environmental stress. Here we
show that in PCs, the S. epidermidis biofilm matrix is mainly of a proteinaceous nature with
extracellular DNA, in contrast to the predominant polysaccharide nature of the biofilm matrix
formed in TSBg cultures. PG profile studies demonstrated that the PG of biofilm cells remod-
els during PC storage displaying fewer muropeptides variants than those observed in TSBg.
The PG muropeptides contain two chemical modifications (amidation and O-acetylation)
previously associated with resistance to antimicrobial agents by other staphylococci. Our
study highlights two key structural features of S. epidermidis that are remodeled when
exposed to human platelets and could be used as targets to reduce septic transfusions
events.
Introduction
Staphylococcus epidermidis is part of the normal human skin microbiome [1, 2]. It helps in the
maintenance of a healthy skin, outcompeting harmful microorganisms such as Staphylococcus
aureus [3, 4]. Although S. epidermidis does not produce virulence factor such as exotoxins, it
has emerged as a significant opportunistic pathogen associated with healthcare-associated
infections [3, 5]. Its ability to adhere to plastics for medical use and subsequent formation of
surface-attached aggregates of bacteria known as biofilms is its most important virulence trait
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[3–5]. In transfusion medicine, S. epidermidis is the most frequent aerobic pathogen isolated
from contaminated platelet concentrates (PCs), a blood product administered to patients with
bleeding disorders [6]. PCs can be manufactured by pooling buffy coat fractions obtained
from whole blood donations of four to five donors. The pooled buffy coats are suspended in
the plasma of one of the donors. Alternative, PCs can be collected from a single donor using
an apheresis (centrifugation) device. Independently of the manufacturing method, the final PC
product can be suspended in plasma or in a mix of plasma and a buffering additive solution
[7]. PCs are susceptible to bacterial contamination due to their storage conditions in gas-per-
meable plastic bags, containing high concentration of glucose, incubated at 20–24˚C with agi-
tation for up to 7 days, all of which are amenable for bacterial growth. A number of practices
such as donor skin disinfection, diversion of the first aliquot of the donated blood, PC sterility
testing using culture methods, and pathogen reduction technologies, have been implemented
to minimize the risk of transfusing bacterially–contaminated blood products [7]. Biofilm for-
mation in PCs has been shown to increase missed detection during sterility screening [8, 9].
Proliferation of S. epidermidis in the PC storage environment may be linked to its ability to
form biofilms, which confer protection from host defense molecules such as antimicrobial
peptides (AMPs) derived from platelets [2, 10–14]. We have recently demonstrated that
although AMPs could prevent biofilm formation by S. epidermidis, established mature staphy-
lococcal biofilms are resistant to the bactericidal action of these immune factors [15]. Interest-
ingly, S. epidermidis isolates displaying a biofilm-negative phenotype convert to a biofilm-
positive phenotype when grown in PCs, dependant on the presence of plasma factors [8, 16,
17]. Typical biofilm formation in S. epidermidis depends on the production of the exo-polysac-
charide intracellular adhesin (PIA), encoded by the icaADBC operon. PIA mediates the accu-
mulation stage of biofilm formation and is the main component of the biofilm matrix [18, 19].
Some PIA-negative strains are able to form biofilms in an ica-independent manner involving
several cell wall anchored proteins [18, 20], while others display a biofilm-negative phenotype
[21]. Interestingly, certain strains are able to switch between PIA-dependent and protein-
dependent biofilm formation with chemical changes in the structure of the biofilm matrix [22,
23]. Biofilm formation is a highly regulated process that involves a wide number of molecular
factors including cell-surface proteins involved in adhesion to biotic or abiotic surfaces (Bhp,
AltE, SSP-1 and SSP2) or the biofilm accumulation phase (Aap, Embp); extracellular DNA
(eDNA); and teichoic acids (TA) [24, 25]. Importantly, relative amounts of the biofilm matrix
components such as PIA and TA are dependent on growth conditions [26]. The matrix is a
mesh of molecules that interact with each other, for example, Aap can be covalently linked to
peptidoglycan (PG) forming fibril-like structures [27, 28]. Similarly, TA increase bacterial
adhesion to fibronectin-coated surfaces and contribute to biofilm formation [24].The study of
the PG profile in S. epidermidis has not gained much attention in comparison to other staphy-
lococci [29, 30]. Here we show that changes in the PG and biofilm matrix structure occur dur-
ing biofilm formation of S. epidermidis in buffy coat PCs suspended in plasma. We explored
the PG composition of S. epidermidis cells from mature biofilms formed in PCs compared to
biofilm cells grown in laboratory media under optimal growth conditions. Furthermore, we
explored the changes in the biofilm matrix composition and structure of S. epidermidis bio-
films formed in PCs.
Materials and methods
Bacterial strains and culture methods
Four S. epidermidis isolates from the strain collection of Canadian Blood Services were used in
this study, including two isolates form contaminated PCs ST10002 (biofilm-positive) and
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ST11003 (biofilm-negative), and two isolates from the skin of healthy volunteers, AZ22 and
AZ39 (both biofilm-positive) [31]. S. epidermidis 9142 (biofilm-positive) and 9142ΔicaA (bio-
film-negative) [32] were used as biofilm-positive and biofilm-negative controls, respectively.
Bacterial cultures were routinely grown under standard conditions in Trypticase Soy Broth
(TSB) at 37˚C or in PCs under standard PC storage conditions (20–24˚C, under constant agi-
tation for five days).
Congo red agar assay
Production of PIA was tested as described previously [33]. Congo red agar plates were pre-
pared with sterile Brain Heart Infusion agar with the addition of filter-sterilized 0.8 g/ L Congo
red stain (Sigma-Aldrich Canada Ltd., Oakville, Canada) and 36 g/ L of saccharose (Sigma-
Aldrich Canada Ltd., Oakville, Canada). Qualitative PIA production by S. epidermidis isolates
were tested by plating on Congo red agar plates followed by incubation for 48 h at 37˚C. PIA-
producing isolates form black, dry, crusty colonies due to the interaction of the Congo red dye
with the polysaccharide matrix, while PIA-negative isolates form pink or reddish creamy colo-
nies. S. epidermidis 9142 and S. epidermidis 9142 ΔicaA were used as positive and negative con-
trols for PIA production, respectively.
Platelet concentrates preparation
Ethical approval for this study was granted by the Canadian Blood Services Research Ethical
Board. PCs were prepared from whole blood donations using the buffy coat method at the
Canadian Blood Services Network Centre for Applied Development (netCAD, Vancouver,
BC, Canada) in agreement with Canadian Blood Services procedures [34]. PCs were sus-
pended in plasma and shipped to the Canadian Blood Services Centre for Innovation microbi-
ology laboratory in Ottawa, Ontario, Canada, where they were screened for baseline bacterial
contamination following standard procedures [35]. Buffy coat pooled PCs are required to
contain� 240 x 109 platelets/pool.
Biofilm matrix disruption assay
Biofilm formation assays were performed as described [16] briefly: overnight cultures were
adjusted to ~107 colony forming units (CFU)/ml, 3 ml aliquots of bacterial suspension in TSBg
or PCs were added to 6-well polystyrene plates (Falcon, Corning Inc., Durham, NC). The
6-well plates were incubated for 24 hours at 37˚C to allow for biofilm formation in TSBg or for
5 days under PC storage conditions for biofilm formation in PCs. Following incubation, super-
natants were discarded, and biofilms were washed three times using PBS (pH 7.4). To semi-
quantify the protein composition of biofilm matrices, 2.9 ml of 100 μg/ml proteinase K
(Sigma-Aldrich, Oakville, Canada) was added to the grown biofilms in a 20mM Tris and 100
mM NaCl buffer (pH = 7.5) for 2h as previously described [36]. Alternatively, to determine the
DNA composition of the biofilm matrices, 2.9 ml of 0.5 mg/ml DNase I (DN25; Sigma) in 5
mM MgCl2 was added to grown biofilms for 24h. Following incubation with the respective dis-
ruptive agent (proteinase K or DNaseI), residual biofilms were quantified using the semi-
quantitative crystal violet assay [37]. Biofilms were rinsed three times with 1X PBS and stained
with 0.3% Gram crystal violet dye (BD Biosciences, MD, USA) for 30 min. Staining was eluted
with 80:20 ethanol: acetone solution for 15 min. Six 200 μL aliquots of the de-stained solution
from each well were transferred to a 96-well polystyrene plate (Falcon, Corning Inc., Durham,
NC), and the absorbance at 492 nm was measured with an Expert Plus microplate reader (Bio-
tech, Montreal, Canada). To quantify and determine formation of biofilm, we followed the rec-
ommendations for assessment of biofilm production by staphylococci [38]. For assays in PCs,
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the only modifications to the above protocol were that 6 ml of disrupting agent was added to
each well in order to cover the biofilm formed on the sides of the well.
Detection of the PIA by immune dot-blot test
Immuno-dot blots were performed to detect PIA production by S. epidermidis isolates. Briefly,
S. epidermidis biofilms were grown in TSBg and PCs. Supernatants were discarded, and the
adhered biofilms were scraped off the plates and suspended in 1X PBS (pH = 7.4) followed by
centrifugation at 5000g for 10 min and boiling in 0.5 M EDTA (pH = 8.0; Thermo Fisher Sci-
entific, Whitby, Canada) for 5min to lyse cells and release any cell wall-bound PIA into the
supernatants. The boiled samples were centrifuged, and the supernatants were treated with
10 μL of 10 mg/ml proteinase K (Sigma-Aldrich, Oakville, Canada) for 1 h at 37˚C. Proteinase
K activity was stopped by heating at 95 ˚C for 5 min. A 2 μL sample of each supernatant was
spotted onto a nitrocellulose membrane. The membrane was blocked using bovine serum
albumin and then incubated with 1:5,000 anti-S. epidermidis PIA-specific antiserum kindly
provided by Dr. D. Mack (Swansea University, UK) [39]. After washing, the bound antibodies
were detected with an alkaline-phosphatase conjugated anti-rabbit IgG (Sigma-Aldrich,
Oakville, Canada). The membrane was washed, and subsequently incubated with 5-bromo-
4-chloro-3’-indolyphosphate and nitro-blue tetrazolium developer (Sigma-Aldrich, Oakville,
Canada) for 5 min. Membranes were visualized using a MultiImage Light Cabinet and AlphaI-
mager 2200 software (Fisher Scientific, St-Laurent, Quebec). S. epidermidis 9142 was used as
positive control for PIA production, while S. epidermidis 9142 ΔicaA was used as the negative
control.
Statistical analysis
Mean and standard deviation were calculated for each strain in both growth environments
(TSBg and PCs). A mixed model analysis was performed to test the difference between treated
and untreated biofilms with proteinase K or DNase I. In the model, replication ID was fitted as
random effects to control the potential clustering effect. Data from the two study environ-
ments were analysed separately. A p-value of<0.05 was considered statistically significant. All
the analyses were performed in SAS software (SAS Institute Inc., SAS/STAT 9.3).
Fluorescence Microscopy of S. epidermidis biofilms in TSBg and PCs
The composition of S. epidermidis biofilms was observed by Confocal Laser Scanning Micros-
copy (CLSM). Biofilms of S. epidermidis strains ST10002 and AZ39 were grown in either TSBg
or PCs on PC-bag coupons (~7x10 mm), cut from Terumo 804440 bags (TerumoBCT, Lake-
wood, CO); the coupons were placed in 6-well polystyrene plates (Falcon, Corning Inc., Dur-
ham, NC). Initial cultures were inoculated with 107 CFU/ml. The coupons were rinsed with
1X PBS (pH = 7.4), dried briefly in a Petri dish and frozen at -20˚C or kept in PBS at 4˚C. Bio-
films were then labelled with three fluorescent dyes as follows: (I) Wheat germ agglutinin
(WGA) conjugated with Oregon Green-488 (Thermo Fisher Scientific, Waltham, MA, USA)
(WGA-OG488), which labels polysaccharides by binding to N-acetylglucosamine and sialic
acid residues, 5 μm in dH2O/15 min. (II) Film tracer SYPRO Ruby Biofilm Matrix Stain
(Thermo Fisher Scientific, Waltham, MA, USA), which labels most types of proteins, for 15
min prior to live confocal imaging (III) Coupons were then mounted on slides under cover-
slips in DAPI-Fluoromount-G (Electron Microscopy Sciences, Hatfield, PA, USA), containing
4’,6-diamidino-2-phenylindole (DAPI), which labels DNA. Coupons were rinsed for 1 min in
ultrapure water following each of the first two staining steps.
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Samples were imaged using a Zeiss LSM800 Airyscan CLSM (Carl Zeiss MicroImaging,
Göttingen, Germany). For visualisation of WGA, SYPRO and DAPI staining, excitation lasers
of 488 nm, 405 nm and 405 nm were used respectively. For the TSBg samples, emission bands
of 505–555 nm for WGA, 555–700 nm for SYPRO, and 410–505 nm for DAPI were acquired
using the GaAsP detectors and a Plan-Apochromat 40x NA 1.4 oil objective. For the PC sam-
ples, emission bands of 485–560 nm for WGA, 554–700 nm for SYPRO, and 400–530 nm for
DAPI were acquired using the high resolution Airyscan detector and a Plan-Apochromat 63x
NA 1.4 oil objective. Images were processed with ZEN 2.3 software (Carl Zeiss MicroImaging,
Göttingen, Germany) and Adobe Photoshop CS6 (http://www.adobe.com/).
For the visualization of eDNA in the biofilm matrix and the DNA in the bacterial cells, a
combination of TOTO-1 (Thermo Fisher Scientific, Waltham, MA, USA) with the cell perme-
able SYTO 60 (Thermo Fisher Scientific, Waltham, MA, USA) [40] was used on biofilms sam-
ples grown in PCs. CLSM analysis of the eDNA content in the biofilm matrix of S. epidermidis
ST10002 (PIA+) and AZ39 (PIA-) in PC was performed using a specific dye for eDNA, SYTO-
60. Biofilms were stained with the eDNA specific cell-impermeant nucleic acid stain TOTO-1
(2 μm for 2 min) and counterstained with the cell-permeant nucleic acid stain SYTO-60
(10 μm for 2 min). Samples were visualized using excitation lasers of 488 nm and 640 nm for
TOTO-1 and SYTO-60 respectively. An emission band of 450–630 nm was acquired for
TOTO-1 using the Airyscan detector and an emission band of 656–700 nm was acquired for
SYTO-60 using the GaAsP detector. Differential interference contrast microscopy (DIC) was
used to observe the biofilms without stain. The eDNA staining patterns observed for ST10002
(PIA+) and AZ39 (PIA-) were similar. Biofilms were observed with a 40x objective. Scale
bar = 5 μm.
Scanning electron microscopy (SEM)
Biofilms of S. epidermidis strains ST10002 and AZ39 were grown in either TSBg or PCs on PC-
bag coupons (~7x10 mm), from Terumo 804440 bags (TerumoBCT, Lakewood, CO), which
were placed in 6-well polystyrene plates (Falcon, Corning Inc., Durham, NC). Initial cultures
were inoculated with 107 CFU/ml. The coupons were rinsed with 1X phosphate buffer saline
(pH = 7.4). For SEM imaging, the aggregates were fixed in a 2.5% v/v glutaraldehyde in a 0.1
M sodium cacodylate buffer (pH 7.0) for 10 min at room temperature (22–24 ˚C) and dehy-
drated with graded ethanol concentrations (20, 50, 70, and 100%). The coupons were then crit-
ical point dried, mounted an aluminum SEM stubs, coated with a 9 nm thin layer of gold and
examined in a Philips XL-30 ESEM scanning electron microscope operated at 7.5 kV and a 7.5
mm working distance. Images (2576x1936 pixels) were obtained in TIFF format.
Peptidoglycan extraction
Peptidoglycan was prepared from S. epidermidis biofilm cultures grown in TSBg or PCs fol-
lowing a previously described protocol [41] with slight modifications. Briefly, 50 ml bacterial
cultures adjusted to of 107−108 CFU/ml prepared in in culture flasks (Falcon, Corning Inc.,
Durham, NC) were incubated to allow for biofilm formation for 24h/37˚C in TSBg, or for 5
days/22˚C with agitation in PCs. After incubation, supernatant was discarded and biofilms
were rinsed with 1X PBS (pH = 7.4). Adhered biofilms were then scraped off the flask and sus-
pended in 10 ml 1X PBS (pH = 7.4). Cells were harvested by centrifugation for 15 min at
4000x g at room temperature, resuspended in 3 ml of ddH2O and added to a boiling 10%(v/v)
SDS solution vigorously stirred. The sample was boiled overnight in a water bath without stir-
ring. Sacculi was concentrated by centrifugation for 15 min and the pellet was washed until no
SDS was detected. The pellet, free of SDS, was suspended in 0.5 ml of 10 mM Tris-HCl, 0.06%
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NaCl (pH 7.2) and digested with α-amylase (100 μg/ml) for 90 min at 37˚C and then with
100 μg/ml pronase-E for 1h at 60˚C. PG was further digested in 50 mM phosphate buffer (pH
4.9) with 20 μg/ml Cellosyl (Hoechst AG, Frankfurt, Germany) at 37˚C overnight. The insolu-
ble material was removed by centrifugation, and soluble muropeptides were reduced with
sodium borohydride and frozen at -70˚C.
Analysis of muropeptides using high performance liquid chromatography
(HPLC) and MALDI-TOF mass spectrometry
Muramidase-digested samples were analyzed by high-performance liquid chromatography
(HPLC) as previously described [42]. Briefly, samples were filtered and injected into the
HPLC. Separations were performed on a Waters Breeze 2 HPLC System (equipped with
Waters 1525 Binary HPLC Pump and Waters 2489 UV/Visible Detector). Separation of indi-
vidual muropeptides was performed in a linear gradient, the column was equilibrated at 45˚C,
and eluted compounds were detected at a wavelength of 204 nm. Individual muropeptides
resolved by HPLC, were analyzed by MALDI-TOF carried out at the CMBSO Protein Chemis-
try Facility at the Universidad Autonoma de Madrid, Spain.
Relative quantification of the muropeptides
The relative quantification of the muropeptide content was performed calculating the normal-
ized percentage of the relative corresponding area under each peak, from which the chemical
composition was determined (peaks 1 to 23) adjusted to 100% in each PG profile.
Results
The biofilm matrix of S. epidermidis formed in PCs displays high protein
content
Four S. epidermidis isolates (ST10002, ST10003, AZ22, and AZ39) were grown as biofilms in
PCs and in glucose-supplemented Trypticase Soy Broth (TSBg). ST10002, AZ22 and AZ39 are
biofilm-positive in both TSBg and PCs while S. epidermidis ST11003 displays a biofilm-nega-
tive phenotype in TSBg [31] but converts to biofilm-positive in PCs. Production of a PIA-
based biofilm matrix was assayed by immune dot blot using S. epidermidis 9142 and
9142ΔicaA [32] as PIA-positive (PIA+) and PIA–negative (PIA-) controls, respectively. Fig 1a
shows that a PIA-based biofilm matrix was detected in ST10002 grown in PCs and TSBg, but it
was absent in AZ39 and AZ22. A Congo red agar assay supported these results showing posi-
tive PIA production by S. epidermidis ST10002 and a PIA-negative phenotype for strains
AZ39, AZ22 and ST11003 (Fig 1a).
Mature biofilms of the four isolates were treated with proteinase K to determine the relative
amounts of protein in the biofilm matrix [36]. In TSBg, PIA+ S. epidermidis 9142 showed
approximately 10% of biofilm reduction after proteinase K treatment (p = 0.1206) while bio-
films of S. epidermidis ST10002, also a PIA+ strain, were reduced by 25.4% post proteinase K
treatment (p = 0.0301) (Fig 1b and S1 Table). In contrast, strains AZ22 and AZ39, which clas-
sify as moderate and strong biofilm formers, respectively, according to the classification of Ste-
panovic and colleagues [38], and do not carry the icaA and icaD genes (i.e., PIA-) [31], were
highly susceptible to proteinase K treatment. After exposure to proteinase K, S. epidermidis
AZ22 biofilms showed 85.6% reduction (p = 0.0229) and AZ39 biofilms displayed a 96.4%
reduction (p = 0.0044) (Fig 1b and S1 Table). Results showed that the chemical composition of
the matrix of S. epidermidis biofilms formed in PCs by all strains was predominantly of a
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proteinaceous nature. Biofilms were highly disrupted (>73%) after treatment with Proteinase
K (Fig 1b).
To determine the relative amounts of eDNA in the biofilm matrix, mature biofilms were
treated with DNase I. In TSBg, biofilms of strains 9142, AZ22, AZ39 and ST10002 were signifi-
cantly disrupted after incubation with DNase I for 24h (Fig 1c and S2 Table). Percent biofilm
reduction for strains 9142, AZ22, AZ39 and ST10002 was 42.2% (p = 0.0219), 95.9% (p =
0.0206), 90.0% (p = 0.0077) and 88.8% (p = 0.0004), respectively (S2 Table). None of the strains
exhibited biofilm disruption with DNase I treatment when grown in PCs. This was likely due
to the fact that S. epidermis biofilms incubation with DNase I for several days could be less sus-
ceptible to disruption [43] and/or an excess of eDNA in the growing medium that can prevent
the effect of DNase I treatment as shown in S. aureus [44]. To overcome these issues, we fur-
ther investigated the presence of eDNA in the S. epidermidis biofilms formed in PCs, using
microscopy techniques.
Structure of the S. epidermidis biofilm matrix is remodelled in PCs
compared to laboratory optimal conditions and it is mainly made of
proteins and eDNA
We investigated the macromolecular biofilm matrix composition and the biofilm structure of
two S. epidermidis strains ST10002 (PIA+) and AZ39 (PIA-) in PCs and TSBg. Biofilms were
grown on plastic coupons prepared from PC bags. The biofilm matrices of both strains were
Fig 1. Biofilm matrix composition of S. epidermidis. a) PIA production by S. epidermidis biofilms. Left panel, cultures on Congo red agar plates: PIA production
is shown by formation of dark crusty colonies while PIA-negative strains form smooth pink colonies. Dot-blots using anti-PIA antibodies shows dark circles for
PIA+ strains. b) Protein detection in S. epidermidis biofilms. A proteinase K disruption assay show presence of a proteinaceous matrix in S. epidermidis biofilms
grown in TSBg or PCs. Black bars show untreated biofilms while grey bars show disrupted biofilms. c) eDNA detection in S. epidermidis biofilms. A DNase I
disruption assay show presence of eDNA in the matrix of S. epidermidis biofilms grown in TSBg. None of the strains exhibited biofilm disruption with DNase I
treatment when grown in PCs.. Black bars show untreated biofilms while grey bars show treated biofilms. � (p< 0.05) and �� (p< 0.005).
https://doi.org/10.1371/journal.pone.0211132.g001
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simultaneously stained with fluorescent dyes for polysaccharides (WGA-OG488), proteins
(SYPRO-Ruby), and DNA (DAPI) and analyzed using Confocal Laser Scanning Microscopy
(CLSM). Scanning electron microscopy (SEM) was used to explore the structure of the bio-
films on the coupons.
In TSBg, ST10002 displayed extensive staining by both WGA-OG488 and SYPRO-Ruby,
while AZ39 showed staining by SYPRO-Ruby but little by WGA-OG488 (Fig 2). This suggests
that in TSBg, the biofilm matrix of ST10002 comprises both polysaccharides and proteins
while the biofilm matrix of AZ39 is predominantly proteinaceous. In both strains, the
WGA-OG488 and SYPRO-Ruby staining overlapped the DAPI-stained bacteria and eDNA
(Fig 2).
Coupons incubated in TSBg or PCs without bacteria were used as controls. The TSBg con-
trol coupons did not show any staining (Fig 2). The PC control coupons, however, showed
both WGA-OG488 and SYPRO-Ruby staining of globular structures, that did not show any
Fig 2. Macromolecular composition of the S. epidermidis biofilm matrix. CLSM analysis of the biofilm matrix composition of S. epidermidis ST10002 (PIA+) and
AZ39 (PIA-). WGA-OG488 staining shows polysaccharide content attributed to PIA production. SYPRO-Ruby staining shows proteins contained in the biofilm
matrix and DAPI staining was used to detect DNA and visualize bacteria. TSBg biofilms were observed with a 40x objective. Scale bar = 20 μm. PC biofilms were
observed with a 63x objective. Scale bar = 5 μm. TSBg coupons were stored at 4˚C in PBS 1x before staining while PC coupons were rinsed with PBS 1X, dried, and
stored at -20˚C before staining.
https://doi.org/10.1371/journal.pone.0211132.g002
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DAPI staining, indicative of PC polysaccharide and protein components adsorbed by the plas-
tic coupons (Fig 2). In PCs, ST10002 and AZ39 were observed to associate with these adsorbed
PC components, perhaps using them as foundations from which to further develop biofilms
(Fig 2). Whereas WGA-OG488 staining in PC grown ST10002 and AZ39 seemed to be primar-
ily associated with PC components, SYPRO-Ruby staining more closely overlapped the DAPI-
stained bacteria (Fig 2). Thus, the biofilm matrix of both ST10002 and AZ39 biofilms grown in
PCs is associated with adsorbed protein and polysaccharide PC components but is itself more
proteinaceous.
Since DAPI stained both the bacterial DNA and biofilm eDNA, precluding conclusions
regarding differential eDNA content between the two strains, the fluorescent eDNA stain
TOTO-1 and the total DNA counterstain SYTO-60 were used to examine the eDNA content
of the biofilms. In PCs, both S. epidermidis strains showed similar staining patterns (Fig 3).
SEM micrographs of the biofilms of ST10002 and AZ39 formed in PCs compared to TSBg
revealed a different structure. In TSBg, ST10002 formed thick multilayered biofilms while
AZ39 formed monolayered biofilms (Fig 4). In PCs, the structure of the biofilms of ST10002
and AZ39 were not visually different and biofilms from both strains displayed a thick multilay-
ered biofilm structure (Fig 4).
The PC milieu induces structural changes in the peptidoglycan of S. epidermidis biofilm
cells. Because structural changes in the biofilm matrix may also affect the composition of the
cell wall of biofilm cells, we studied the composition of the PG of S. epidermidis ST10002 and
AZ39 biofilms cells grown in TSBg and PCs using HPLC and MS techniques. The analysis was
restricted to early eluting components (muropeptides), due the complexity of the staphylococ-
cal peptidoglycan. The muropeptides, upon MS examination, were found to represent varia-
tions of the basic monomeric subunit N-acetylglucosamine (NAG)-N-acetylmuramic acid
(NAM)-L-Ala-D-Gln (γ-L-Lys-[ε-Gly5]-D-Ala-D-Ala, similar to the basic monomers of S.
aureus. The variations (Table 1) included: muropeptides with 2,6-N,O-diacetylmuramic acid
(NAMOAc); different numbers of Gly residues and substitutions of one or more Gly for Ser or
Ala in the bridge peptide; and a number of D-Ala residues. Unexpectedly, the most abundant
muropeptide in all instances had a single alanine residue as a bridge peptide (NAG-NAM-A-
Q-K(ε-A)-A-A) (Table 1) instead of the canonical poly-Gly (penta)peptide of staphylococcal
PG.
Our results indicated a strong influence of the growth environment on the PG composition
with similar consequences in both strains. These effects resulted in clearly different HPLC elu-
tion patterns (Fig 5 and Fig A in S1 Fig), more complex in the case of biofilms formed in TSBg
compared to those formed in PCs. In fact, many of the late eluting components, between Rt 25
to 40 min, were missing in PG from biofilms formed in PCs. Indeed, the proportions of muro-
peptides with Ser in the bridge peptides, with NAMOAc, with complete (pentapeptidic) bridge
peptides, and with D-ala-D-ala as C-terminal dipeptide were all considerably higher in the PG
profile from TSBg than from PCs cultures (Table 1).
Furthermore, there was a substantial shift in the nature of the predominant muropeptides
from subunits with intact (pentapeptidic) bridge peptides (such as muropeptides with peak
numbers 6, 7, 9, 12, 14, 17 and 20) into subunits with a truncated, or missing, bridge-peptide
(like muropeptides 1, 2, 8, 12), as shown in Table 1. Comparison of the muropeptide composi-
tion for ST10002 (PIA+) and AZ39 (PIA-) strains grown in TSBg displayed the presence of the
same muropeptides but at substantially different proportions. In fact, AZ39 PG had about
three times as many Ser-containing muropeptides and twice as many subunits with peptapep-
tidic bridge-peptides as ST10002 but had a lower degree of O-acetylation (Table 1). Because
both strains respond similarly when grown in PCs, the differences between them are main-
tained, with the exception of O-acetylation, which under these conditions is higher in AZ39
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than in ST10002 (Fig A in S1 Fig). Assuming that the results from the analysis of the mono-
meric subunits is a faithful reflection of total PG, our data support a strong influence of both,
environmental conditions and ability to form PIA-based biofilms on PG composition.
Discussion
In the present work, we have shown that S. epidermidis biofilm cells undergo structural
changes in their PG and biofilm matrix composition when grown in buffy coat PCs compared
Fig 3. eDNA presence in S. epidermidis biofilms formed in PCs. CLSM analysis of the DNA content of the biofilm
matrix of S. epidermidis ST10002 (PIA+) and AZ39 (PIA-) formed in PCs. Biofilms were stained with the eDNA
specific cell-impermeant nucleic acid stain TOTO-1 and counterstained with the cell-permeant nucleic acid stain
SYTO-60. Samples were visualized using excitation lasers of 488 nm and 640 nm for TOTO-1 and SYTO-60
respectively. An emission band of 450–630 nm was acquired for TOTO-1 using the Airyscan detector and an emission
band of 656–700 nm was acquired for SYTO-60 using the GaAsP dectector. Differential interference contrast
microscopy (DIC) was used to observe the biofilms without stain. The eDNA staining patterns observed for ST10002
(PIA+) and AZ39 (PIA-) were similar. Biofilms were observed with a 40x objective. Scale bar = 5 μm.
https://doi.org/10.1371/journal.pone.0211132.g003
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to optimal laboratory conditions. PCs are known to provide ideal conditions for bacteria to
grow; however, the PC milieu also provides a stressful environment with bactericidal proper-
ties due to the presence of immune factors such as AMPs [10, 11]. Biofilm formation by S. epi-
dermidis is likely a survival mechanism to resist such antimicrobial factors [15]. The biofilm
has an architecture including the extracellular matrix that provides resistance to antibiotics
and other antimicrobial agents in different environments [45]. Here we have shown that the
biofilm matrix of different S. epidermidis strains in PCs is mainly composed of proteins and
eDNA, which differs from the chemical structure when the bacteria are grown in regular
media. It is important to recognize that proteins associated to the biofilm matrix could also be
plasma proteins present in the PCs. These observations open new questions about alternative
unexplored mechanisms for biofilm formation that are induced when S. epidermidis is grown
in PCs. Understanding of the proteinaceous nature of the biofilm matrix of S. epidermidis
formed in PCs would provide the identification of potential molecular targets to avoid biofilm
formation and consequently improve PC transfusion safety. In S. aureus, formation of a pro-
teinaceous matrix containing cytoplasmic proteins exported to the cell surface has been
described to be linked to a decrease in pH in the growth medium [46]. The molecular mecha-
nisms that regulate this phenomenon remain unclear. The presence of glucose in the growth
medium for bacteria leads to the accumulation of acidic by-products from fermentation that is
critical for the decrease in pH and the induction of biofilms. In PCs, the high levels of glucose
might be one of the factors that contributes to the induction of biofilm formation [47]. It
would be reasonable to hypothesize that the utilization of glucose by bacteria could create a
microenvironment with a decreased pH that stimulates the exportation of cytoplasmic pro-
teins to the cell surface to form a proteinaceous biofilm matrix. Indeed, a decrease in pH in
contaminated PCs has been associated to high titres of bacterial contamination [48, 49].
This is the first study that explored the PG profile of S. epidermidis biofilms formed in PCs.
The muropeptide composition of PG from S. epidermidis, quite similar to S. aureus [50], was
characterized by the presence of D-Gln, penta-Gly bridges, often with either Ser or Ala substi-
tuting for one or more Gly, and muropeptides with O-acetylated NAM. However, S. epidermi-
dis exhibited a distinct abundance of muropeptides with an Ala substituting for the poly-Gly
bridge peptide. The structural changes in the S. epidermidis cell wall surface might be a strategy
Fig 4. Biofilm architecture of S. epidermidis biofilms. SEM micrographs showed different biofilm structures of ST10002 and AZ39 in
PCs compared to TSBg. In TSBg, the samples were tilted< 8˚ and< 4˚, respectively to allow for visualization of thickness of the
biofilms. While ST10002 formed thick multilayered biofilms, AZ39 formed monolayered biofilms. By contrast, in PCs, both strains
displayed a thick multilayered biofilm. Scale bar = 5 μm.
https://doi.org/10.1371/journal.pone.0211132.g004
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to adapt to different environments, in particular to resist clearance by immune factors abun-
dant in PCs [12, 51, 52]. Certainly, the most conspicuous changes observed in our study
involved the proportions of muropeptides with NAMOAc, and with Ser residues in the bridge
peptides. The presence of Ser residues in the poly-Gly bridge peptide, the absence of a poly-
Gly bridge peptide, and the proportion of NAMOAc, modulate resistance of PG against
Table 1. Relative quantification and comparison of the PG muropeptides of S. epidermidis ST10002 (PIA+) and AZ39 (PIA-) biofilm cells grown in TSBg and PCs.
Peak
Number
Chemical composition AZ39 Peak Number Chemical composition ST10002









1, 5 NAG-NAM-A-Q-K-A-A 7.05 41.48 1, 5, 6 NAG-NAM-A-Q-K-A-A 9.87 34.48
2 NAG-NAM-A-Q-K-(G)-A-A 5.67 6.52 2 NAG-NAM-A-Q-K-(G)-A-A 5.99 9.57
2 NAG-NAM-A-Q-K-(G2S3)-A-A 0.25 0.00 2 NAG-NAM-A-Q-K-(G2S3)-A-A 0.00 0.00
2 NAG-NAMOAc-A-Q-K-(S3) 1.95 0.96 2 NAG-NAMOAc-A-Q-K-(S3) 0.81 1.41
3 NAG-NAM-A-Q-K-(G4S)-A 0.66 0.00 3 NAG-NAM-A-Q-K-(G-G-G-G-G)-A 2.69 0.11
4 NAG-NAM-A-Q-K-(G-G)-A-A 2.46 1.62 4 NAG-NAM-A-Q-K-(G-G)-A-A 1.49 3.98
4 NAG-NAM-A-Q-K-(G-G-G)-A-A 0.26 0.00 4,5 NAG-NAM-A-Q-K-(G-G-G)-A-A 0.52 0.97
4 NAG-NAM-A-Q-K-(G3S2)-A-A 0.00 1.11 4,6 NAG-NAM-A-Q-K-(G2S)-A-A 0.00 0.84
4,6 NAG-NAM-A-Q-K-(G2S)-A-A 2.25 2.84 4,15 NAG-NAMOAc-A-Q-K-(G3-S2)-A-A 0.63 1.34
5, 6, 7, 20 NAG-NAMOAc-A-Q-K-A-A 4.47 14.07 5 NAG-NAM-A-Q-K-(G-G-G-G)-A-A 0.22 0.25
6 NAG-NAM-A-Q-K-(S3) 1.55 0.00 5, 6, 7, 20 NAG-NAMOAc-A-Q-K-A-A 7.48 4.30
6, 7, 9 NAG-NAM-A-Q-K-(G-G-G-G-G)-
A-A





13.97 3.95 7 NAG-NAM-A-Q-K-(G-G-S-G-G)-
A-A
0.00 0.00
8 NAG-NAM-A-Q-K-(A)-A-A 14.84 18.33 8 NAG-NAM-A-Q-K-(A)-A-A 22.5 31.60
11 NAG-NAMOAc-A-Q-K-(G-G-G-G-G) 3.54 1.48 11 NAG-NAMOAc-A-Q-K-(G-G-G-G-G) 8.99 3.73
12 NAG-NAMOAc-A-Q-K-
(G-G-G-G-G)-A
0.00 0.71 12 NAG-NAMOAc-A-Q-K-
(G-G-G-G-G)-A
0.89 0.95
12 NAG-NAMOAc-A-Q-K-(G4-S) 3.67 0.00 12 NAG-NAMOAc-A-Q-K-(G4-S) 1.27 0.00
12 NAG-NAM-A-Q-K-(G4A)-A-A 2.57 0.18 12 NAG-NAM-A-Q-K-(G4A)-A-A 0.00 0.00
13 NAG-NAM-A-Q-K-(G3AS)-A-A 7.49 0.00 13 NAG-NAM-A-Q-K-(G3AS)-A-A 2.85 0.00
14 NAG-NAMOAc-A-Q-K-(G)-A-A 0.28 0.00 15 NAG-NAMOAc-A-Q-K-(G)-A-A 0.93 0.00
14 NAG-NAMOAc-A-Q-K-(G2-S)-A 0.17 0.00 15 NAG-NAMOAc-A-Q-K-(G2-S)-A 0.55 0.00
14 NAG-NAMOAc-A-Q-K-(G3-S2)-A-A 0.19 0.00 15, 18, 19, 20 NAG-NAMOAc-A-Q-K-(G4-S)-A-A 6.07 0.00
14, 17, 19, 20 NAG-NAMOAc-A-Q-K-(G4-S)-A-A 7.64 0.13 18 NAG-NAMOAc-A-Q-K-(G2S)-A-A 0.00 0.00
17 NAG-NAMOAc-A-Q-K-(G-G)-A-A 0.64 0.00 18 NAG-NAMOAc-A-Q-K-(G-G)-A-A 0.00 0.00





0.85 0.00 19 NAG-NAMOAc-A-Q-K-(S3) 1.67 0.00
21, 22, 23 NAG-NAMOAc-A-Q-K-(A)-A-A 10.05 2.84 20, 21, 22 NAG-NAMOAc-A-Q-K-(A)-A-A 18.78 3.27
TOTAL (%) 100.02 100.03 TOTAL (%) 100.01 100
PG
Modifications
AZ39 TSBg PC PG
Modifications
ST10002 TSBg PC
Serine muropeptides 50.30 31.66 Serine muropeptides 13.85 3.59
O-acetilation 37.48 5.34 O-acetilation 47.99 13.59
Non A-A muropeptides 38.61 22.41 Non A-A muropeptides 16.87 6.2
S-link 40.38 26.09 S-link 29.20 9.33
% Corr area = corresponding area under a peak
https://doi.org/10.1371/journal.pone.0211132.t001
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potentially damaging enzymes. In particular, these types of muropeptides have been associated
to increased resistance against the PG degrading enzymes lysozyme and lysostaphin [53].
Lysozymes are secreted by neutrophils and macrophages as a defense mechanism. The resis-
tance of S. epidermidis to lysozymes contribute to its pathogenicity and to its ability to colonize
the skin and other human tissues [54]. Surprisingly, the changes detected herein pointed into
an unexpected direction. Our results suggest that the PG of S. epidermidis cells formed in PCs
would be more sensitive to degrading enzymes than the PG of biofilm cells grown in TSBg. It
is possible that PG hydrolytic enzymes are a relatively minor threat for cells in PCs, which war-
rants further exploration. The higher proportion of muropeptides with Ala as a bridge peptide
in PC-grown biofilms could compensate for the lower Ser content, as absence of penta-Gly
also provides lysostaphin resistance. It is therefore postulated that S. epidermidis minimizes the
PG synthesis and synthesizes PG with lower complexity to survive, optimizing energy for
other functions required for optimal proliferation in the adverse PC environment. Amidation
of D-Glu in PG has a profound impact on the physicochemical properties of the molecules
since it removes the negative charge from the D-Glu alpha-carboxyl group [50]. It seems useful
as a general mechanism for S. epidermidis, and other species, to minimize the interaction of
PG with cationic AMPs.
Our study was limited to PCs suspended in plasma prepared by the buffy coat method. We
recognize that although our work highlights how the PC storage environment induces biofilm
matrix and cell wall modification of S. epidermidis, it is unknown how other manufacturing
and/or storage conditions would affect these structural modifications. Although we have previ-
ously shown that the presence of platelets [16] and plasma proteins [17, 55] enhance S. epider-
midis biofilm formation, we have not performed comparative biofilm studies between
apheresis and buffy coat PCs. We have demonstrated that S. epidermidis biofilms are resistant
to AMPs [15]; however, the resistance mechanisms to other immune factors such as lysozymes
present in PCs remain to be investigated. Further studies to address these questions and the
potential differences in biofilm matrix and cell wall modification are warranted. Biofilm matrix
and cell wall remodeling facilitates bacterial survival in an unhospitable environment. Both
features serve S. epidermidis as mechanisms of defense and although they are commonly
Fig 5. Structural changes in the S. epidermidis peptidoglycan in PCs. The peptidoglycan profile of S. epidermidis ST10002 (left) and AZ39 (right) of biofilm cells
formed in PCs (black) and in TSBg (red) are overlapped.
https://doi.org/10.1371/journal.pone.0211132.g005
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studied as two separate systems, here we showed that they are interconnected, as it is the case
of other bacteria [56]. This is the first reported study investigating physiological changes
undergone by bacteria when grown in PCs. It has generated novel insights that could be used
for the development of strategies to mitigate the risk of transfusing bacterially-contaminated
PCs, which is one of the greatest post-transfusion infectious risk worldwide [6, 57].
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